1) Endometriosis
[英][,endəu,mi:tri'əusis] [美][,ɛndo,mitrɪ'osɪs]
子宫内膜异位
1.
Expression of MMP9, TIMP1, VEGF in ectopic and eutopic endometrium in patients with endometriosis;
MMP9、TIMP1及VEGF在子宫内膜异位症患者在位内膜的表达
2.
Detection of Serum CA125 in Endometriosis and its Value of Clinical Diagnose;
血清CA125检测对子宫内膜异位症的临床诊断价值
2) endometriosis
[英][,endəu,mi:tri'əusis] [美][,ɛndo,mitrɪ'osɪs]
子宫内膜异位症
1.
Expression of angiopoietin-1 and-2 in endometriosis and adenomyosis;
Ang-1和Ang-2在子宫内膜异位症及子宫腺肌病中的表达
2.
Comparision of Therapeutical Effect of Gestrinone and desogestrel-chip ethinglestradiol on Endometriosis;
孕三烯酮与去氧孕烯炔雌醇片治疗子宫内膜异位症的疗效比较
3.
The effects of TNF-α and sTNFRⅠ on stormal cells of endometriosis;
TNF-α及sTNFRⅠ对子宫内膜异位症在位内膜基质细胞的作用
3) endometriosis(EMs)
子宫内膜异位症
1.
Objective To explore relationship between intron 1 and codon 10 single nucleotide polymorphisms(SNPs) of estrogen receptor-α(ER-α)and clinical characteristics of endometriosis(EMs).
目的探讨雌激素受体α基因内含子1和编码子10的单核苷酸多态性与子宫内膜异位症(简称内异症)发病及临床特性的关系。
2.
Objective:To evaluate the molecular mechanisms by measuring the gene expression of Survivin and Cox-2 which occur in patients with endometriosis(EMS) and to investigate their effects on the initiation and maintenance of EMS.
目的:通过对临床子宫内膜异位症(endomotriosis,EMS)患者异位内膜及在位内膜Survivin mRNA及Cox-2mRNA表达测定,探讨Survivin及Cox-2在EMS发病及发展中的分子生物学机制及其两者的相关性。
3.
Objective To investigate expression of keratinocyte growth factor(KGF) and change in microvessel density(MVD) in eutopic and ectopic endometria of women with endometriosis(EMs) and their correlation with clinical staging and menstrual cycle of the women.
目的研究角质细胞生长因子及微血管密度在子宫内膜异位症患者卵巢异位组织、在位内膜中的变化及其表达与患者的临床分期及月经周期的关系。
4) ectopic endometrium
异位子宫内膜
1.
Changes of mast cells and eosinophilic granulocytes in ectopic endometrium of rats;
肥大细胞和嗜酸粒细胞在大鼠异位子宫内膜中的变化
5) endometriosis (EMS)
子宫内膜异位症
1.
Experimental research of cellular and humoral immunity in endometriosis (EMS) treated by principle of promoting blood circulation and removing blood stasis, softening hardness and resolving hard masses;
活血化瘀软坚散结法对子宫内膜异位症细胞免疫和体液免疫功能影响的实验研究
2.
Objective To evaluate the molecular mechanism by measuring the gene expression of Survivin,Bcl-2 and Cox-2 in patients with endometriosis (EMS) and investigate their effects on the initiation and maintenance of endometriosis.
目的通过对临床子宫内膜异位症(endometriosis,EMS)患者异位内膜及在位内膜survivin mRNA,bcl-2 mRNA及cox-2 mRNA表达的测定,探讨Survivin,Bcl-2及Cox-2在子宫内膜异位症发病及发展中的分子生物学机制及其三者的相关性。
6) endometaphase
子宫内膜异位的
补充资料：阔韧带子宫内膜异位症
阔韧带子宫内膜异位症
病名。指子宫内 膜异位于阔韧带处者。为子宫内膜异位症类型之一。是盆腔子宫内膜异位的一部分。多发生 于阔韧带底部结缔组织中。临床表现为经前2～3天开始出现下腹痛，月经后疼痛缓解。如果 累及骶丛神经，可引起坐骨神经痛。病理检查可在病变部位找到子宫内膜组织。详参子宫内 膜异位症条。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条